| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
1 The Department of Pathology, Leiden University Medical Centre, P O Box 9600, 2300 RC Leiden, The Netherlands
2 The Department of Clinical Oncology, Leiden University Medical Centre
3 The Department of Gastroenterology, Leiden University Medical Centre
4 The Department of Pathology, University Medical Centre St Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Correspondence: Professor van Krieken email: J.vanKrieken{at}pathol.azn.nl
Background/Aims—Detection of clonal immunoglobulin heavy chain (IgH) rearrangements by the polymerase chain reaction (PCR) is an attractive alternative to Southern blotting in lymphoma diagnostics. However, the advantages and limitations of PCR in clonality analysis are still not fully appreciated. In this study, clonality was analysed by means of PCR, focusing in particular on the sample size requirements when studying extremely small samples of polyclonal and monoclonal lesions.
Materials/Methods—High resolution complementarity determining region 3 (CDR3) PCR was used to investigate the minimum number of cells and the amount of tissue required for the detection of a polyclonal population, both for fresh cells and formalin fixed, paraffin wax embedded tissue. Subsequently, frozen and paraffin wax embedded samples of 76 B cell lymphoproliferative disorders, 43 of which were tested by means of Southern blotting, were analysed to establish the sensitivity of this assay. These specimens included 12 chronic lymphocytic leukaemias (CLLs), nine mantle cell lymphomas (MCLs), 10 follicular lymphomas (FLs), and 45 mucosa associated lymphoid tissue (MALT) lymphomas. The specificity was tested on reactive lymph nodes (n = 19), tonsils (n = 4), peripheral blood lymphocyte fractions (n = 4), and biopsies with gastritis (n = 21).
Results—In reactive tissue, 20 ng of high molecular weight DNA derived from 6.5–9 x 103 B cells was sufficient to obtain a polyclonal PCR result. With smaller amounts "pseudoclonality" could be induced. When using paraffin wax blocks, undiluted DNA isolated from tonsillar tissue of at least 1 mm2 was necessary to obtain a polyclonal pattern. The sensitivity required to detect clonality in paraffin wax embedded and frozen tissue by PCR for FL (40% and 60%, respectively) was lower than that for MALT lymphomas (60% and 86%, respectively), CLL (78% and 89%, respectively), and MCL (88% and 100%, respectively). PCR specificity was 96% and 100% for frozen and paraffin wax embedded tissue, respectively.
Conclusion—The minimum amount of template for CDR3 PCR is approximately 20 ng of high molecular weight DNA or 1 mm3 of B cell rich paraffin wax embedded normal tonsillar tissue, but care has to be taken to avoid pseudoclonality when low numbers of B cells are present. Duplicate or triplicate tests should be performed to avoid misinterpretation. The specificity of the PCR assay is almost 100%, whereas sensitivity depends on a combination of factors, such as lymphoma type and tissue fixation. Because frozen samples yield better results, obtaining fresh material for the PCR assay is recommended, especially when analysing FL and MALT lymphomas.
Key Words: B cell clonality analysis • complementarity determining region 3 • polymerase chain reaction • immunoglobulin gene rearrangement • non-Hodgkin's lymphoma
This article has been cited by other articles:
|
|
 |
|
  P. Kiewe, C. Loddenkemper, I. Anagnostopoulos, M. Reinwald, E. Thiel, and A. Korfel High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma Neuro-oncol, April 1, 2007; 9(2): 96 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Parrens, N Carrere, K Bouabdallah, O Fitoussi, J-F Goussot, P Dubus, A de Mascarel, and J-P Merlio Splitting bone marrow trephines into frozen and fixed fragments allows parallel histological and molecular detection of B cell malignant infiltrates. J. Clin. Pathol., October 1, 2006; 59(10): 1111 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lassmann, U. V. Gerlach, K. Technau-Ihling, M. Werner, and P. Fisch Application of BIOMED-2 Primers in Fixed and Decalcified Bone Marrow Biopsies: Analysis of Immunoglobulin H Receptor Rearrangements in B-Cell Non-Hodgkin's Lymphomas J. Mol. Diagn., November 1, 2005; 7(5): 582 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Werner, J. C. Woo, W. Vernau, P. S. Graham, R. A. Grahn, L. A. Lyons, and P. F. Moore Characterization of Feline Immunoglobulin Heavy Chain Variable Region Genes for the Molecular Diagnosis of B-cell Neoplasia Vet. Pathol., September 1, 2005; 42(5): 596 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Fernandez-Ruiz, M. Cabrerizo, M. Ortega, C. Blas, P. Llamas, M. Santos-Roncero, S. Nieto, A. Acevedo, G. Perez, C. Nicolas, et al. High Molecular Response Rate and Clinical Correlation in Patients with Follicular Lymphoma Treated with Cyclophosphamide-Vincristine-Prednisone plus Interferon {alpha} 2b Clin. Cancer Res., July 1, 2003; 9(7): 2497 - 2503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bagg, R. M. Braziel, D. A. Arber, K. E. Bijwaard, and A. Y. Chu Immunoglobulin Heavy Chain Gene Analysis in Lymphomas: A Multi-Center Study Demonstrating the Heterogeneity of Performance of Polymerase Chain Reaction Assays J. Mol. Diagn., May 1, 2002; 4(2): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Molecular Pathology | Journal of Clinical Pathology |
